A prospective cohort study analyzing humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH
Latest Information Update: 12 Oct 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 12 Oct 2022 New trial record
- 06 Oct 2022 Results published in the Journal of Infectious Diseases